SNP microarray analyses reveal copy number alterations and progressive genome reorganization during tumor development in SVT/t driven mice breast cancer by Standfuß Christoph et al.
Standfuß etal. BMCCancer 2012, 12:380
http://www.biomedcentral.com/1471-2407/12/380
RESEARCH ARTICLE Open Access
SNP microarray analyses reveal copy number
alterations and progressive genome
reorganization during tumor development in
SVT/t driven mice breast cancer
Christoph Standfuß1, Heike Pospisil1* and Andreas Klein2
Abstract
Background: Tumor development is known to be a stepwise process involving dynamic changes that aﬀect cellular
integrity and cellular behavior. This complex interaction between genomic organization and gene, as well as protein
expression is not yet fully understood. Tumor characterization by gene expression analyses is not suﬃcient, since
expression levels are only available as a snapshot of the cell status. So far, research has mainly focused on gene
expression proﬁling or alterations in oncogenes, even though DNA microarray platforms would allow for
high-throughput analyses of copy number alterations (CNAs).
Methods: We analyzed DNA from mouse mammary gland epithelial cells using the Aﬀymetrix Mouse Diversity
Genotyping array (MOUSEDIVm520650) and calculated the CNAs. Segmental copy number alterations were
computed based on the probeset CNAs using the circular binary segmentation algorithm. Motif search was
performed in breakpoint regions (inter-segment regions) with the MEME suite to identify common motif sequences.
Results: Here we present a four stage mouse model addressing copy number alterations in tumorigenesis. No
considerable changes in CNA were identiﬁed for non-transgenic mice, but a stepwise increase in CNA was found
during tumor development. The segmental copy number alteration revealed informative chromosomal
fragmentation patterns. In inter-segment regions (hypothetical breakpoint sides) unique motifs were found.
Conclusions: Our analyses suggest genome reorganization as a stepwise process that involves ampliﬁcations and
deletions of chromosomal regions. We conclude from distinctive fragmentation patterns that conserved as well as
individual breakpoints exist which promote tumorigenesis.
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Background
Cancer is known to be a disease involving dynamic
changes aﬀecting cellular integrity and cellular behav-
ior [1]. To date, research has been focused on discov-
ering gene expression proﬁles, alterations in oncogenes
or tumor-suppressors, and genetic mutations; but since
tumorigenesis is a complex multistep process, the trans-
formation of a normal cell into a malignant tumor is
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not completely understood. It has been well known
for decades that alternative pathways in cell transfor-
mation (e.g. changes in cell cycle, signal transduction,
metabolism,immuneresponse)viaastepwiseprogression
to ﬁnal malignant tumors exist [1-4].
In fact, genomic DNA is more stable than mRNA
or proteins [5]. As a consequence of this, the focus
on gene expression proﬁles may not completely reveal
all genetic mechanisms of tumor development and pro-
gression. The alteration of chromosomal copy num-
bers is known to be a key genetic event in many
well-studied diseases [5], such as Jacobsen syndrome
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[6], HIV acquisition and progression [7], systematic
autoimmune diseases [8,9] and cancer phenotypes [10].
In normal human organisms more than 3% of the
genome is known to be aﬀected by copy number alter-
ations (CNAs, also known as copy number variations -
CNV) [11,12], whereas in mice the estimates diﬀer from
3% [13] to 10.7% [14]. Signiﬁcant eﬀorts have been made
to study CNAs in various organisms. Single nucleotide
polymorphism (SNP) oligonucleotide microarrays and
array comparative genomic hybridization (aCGH) allow
for high-throughput analyses of CNAs. This enables the
study of complex genomes and genetic events at a high
resolution. Several studies have addressed CNAs in indi-
viduals from diﬀerent mouse strains: Henrichsen et al.
[14] and Cahan et al. [13] studied the impact of CNAs
on the transcriptome, Cutler et al. [15] analyzed the gene
content of inbred mouse strains, Graubert et al. [16] stud-
ied segmental DNA copy number alterations. Agam et al.
[17] compared the CNAs found in the four mentioned
studies with their own data and found signiﬁcant dif-
ferences. They show that 1.3% to 88.7% of the detected
deletions and 2.1% to 100% of the gains are replicated
from one study to the following ones. They infer that the
reproducibility of these experiments depend on the array
platform, the CNA detection algorithm and the protocols
forplatformdesignandhybridization.Moreover,microar-
ray experiments in humans have revealed a connection
between high ampliﬁed genes and gene expressions [18],
and CNAs aﬀecting well-characterized regions harbor-
ing tumor-suppressor genes in breast cancer and lung
carcinoma [19]. Therefore, the development of highly reli-
able and high-resolution genetic analysis approaches as
presented by Hannemann et al. [10], is of high thera-
peutical relevance. To investigate the impact of CNAs
on gene expression, several studies used network-based
approaches [20-23]. For example, the study of J¨ ornsten
et al. [20] used a global model of CNA-driven transcrip-
tion to model mRNA expressions with the help of CNAs.
In the current study, we investigated the CNAs in a
fourstagetumorigenesismodel.Thismodelincludedcopy
number analyses in non-transgenic NMRI mice (normal;
stage 1 in Figure 1) and in transgenic SVT/t mice: non-
malignant hyperplastic mammary glands and breast can-
cers, as well as breast cancer derived cell lines (stages 2-4
in Figure 1, respectively). The WAP-SVT/t hybrid gene
construct consists of the Wap (Whey acidic protein) pro-
moter fused to the SV40 early coding region [3]. The
WAP-SVT/t expression is selectively activated in breast
tissue during pregnancy and continues after weaning. All
female mice developed breast cancer after the ﬁrst lac-
tation period. We have established the 762TuD breast
cancer cell line (termed sens. cell line) from a WAP SVT/t
tumor, which has switched oﬀ SVT/t expression dur-
ing the cultivation process and developed a p53 hotspot
mutation (G242). The 762TuD cells are immortalized,
malignant transformed and highly aneuploid. Addition-
ally, we established a drug resistant 762TuD cancer cell
line (termed res. cell line). The karyograms (via mFISH) of
these two cell lines (named SVTneg1) are published ([24],
page 91). We focused our research on copy number analy-
ses to compare the genomic alterations that occur during
tumorigenesis. We addressed the question, whether com-
monpredisposedchromosomalbreakpointscouldbeseen
to promote malignant transformation. We can report a
characteristic increase of copy number alterations from
stageonetofour(seeFigure1)inourmodel.Furthermore,
we have identiﬁed continuous regions of copy number
alteration (chromosomal segments) and found character-
istic fragmentations. CNAs were compared on both the
SNP probeset level and the level of continuous CNA
regions (segments). Motif search was performed in hypo-
thetical DNA breakpoint regions to ﬁnd common motifs
that may be coincident with a DNA break. The results of
our model were compared to a model of PIK3CA-driven
mammary tumors presented by Liu et al. [25].
Results and discussion
To study the chromosomal aberrations and diﬀerences
in gene expression at diﬀerent stages of tumorigenesis, a
mouse breast cancer model was applied (see Figure 1). To
probe for chromosomal copy number alterations (CNAs)
in this model we analyzed SNP arrays from mouse mam-
mary gland epithelial cells. Eight samples were taken from
two non-transgenic NMRI mice (normal) on the ﬁrst day
of lactation, two transgenic WAP-SVT/t mice on the ﬁrst
day of lactation, two WAP-SVT/t mouse breast cancer
samples, and two WAP-SVT/t breast cancer derived cell
lines (see Figure 1 and Table S1 in Additional ﬁle 1 for
sample description). Copy number alterations were calcu-
lated from signal intensities detected by high-throughput
single nucleotide polymorphism (SNP) microarrays.
For diploid organisms the usual copy number is
expected to be two, and variations indicate chromosomal
breakpoint events that are proposed to lead to phenotypic
changes, e.g. to pathological aberrations. We searched in
breakpoint regions for common sequence motifs. Addi-
tionally, we considered the gene expression in the context
of chromosomal aberration. A road map of the experi-
m e n t a la p p r o a c hi sg i v e ni nF i g u r e2 .
Furthermore, the results presented in this work were
compared to the data of six recurrent tumor samples
published by Liu and coworkers [25].
SNP copy number alteration
We analyzed 584,729 SNPs for each of the eight sam-
ples with the Aﬀymetrix Mouse Diversity Genotyping
array (see Yang et al. 2009 [27] for additional informa-
tion), and calculated SNP copy number alterations (CNA)Standfuß etal. BMCCancer 2012, 12:380 Page 3 of 15
http://www.biomedcentral.com/1471-2407/12/380
Figure 1 Overview of mouse sample origin. Mammary gland tissue samples from six NMRI mice were analyzed. Two normal samples were
derived from two NMRI mice (A) and four mammary gland samples were derived from transgenic WAP-SVT/t mice. The transgenic samples (B)
originate from these WAP-SVT/t mice, taken at ﬁrst day of lactation. After the ﬁrst lactation period all WAP-SVT/t transgenic mice had developed
breast cancer. The two tumor samples were taken from these mice (C). Additionally, two samples from two cell lines were used (D). As described by
Klein et al. [24] these two cell lines were established from mammary gland tumors (E). The Kaplan-Meier survival curve for tumor-free survival after
ﬁ r s tm a t i n gi sd e p i c t e d(F) and the mean latency is marked in blue. A full version of the Kaplan-Meier curve can be found in Figure S1 (Additional ﬁle
2). The mouse picture was provided by Seans Potato Business and downloaded from Wikimedia Commons.
during tumorigenesis, which are indicators for chromoso-
mal aberrations [10]. We added up the signal intensities
for SNP alleles and compared the total intensities of all
samples against a reference data set (mean signal inten-
sity of both normal samples). For each SNP, CNA was
computed by log2-ratios and all values in the range of
−0.2 <=×<= 0.2 were considered as unchanged which
corresponds to a fold change between 0.87 and 1.15. This
indicates that not more than 30% of the cells carry the
CNA. Compared to normal tissues a signiﬁcant increase
in the number of CNA was detected in the tumors (Welch
t w os a m p l et w o - s i d e dt - T e s tp = 8.43 ∗ 10−8). For visu-
alization, log2-ratio copy number values of the SNPs were
ranged into ﬁve groups to compare changes in diﬀer-
ent samples (see Figure 3A). We categorized the CNAs
to unchanged (-0.2 <=×<= 0.2), slightly increased
(0.2 < × < 0.6, orange), slightly decreased (-0.6 < × <
-0.2, light blue), highly increased (× >= 0.6, red) and
highly decreased (-0.6 <=× , dark blue). 96% of the
SNP signal intensities were found to be unchanged in
both normal samples (Normal1 and Normal2) (depicted
in Figure 3A). These ﬁndings are in concordance with
previously published studies [13,14]. In comparison, 10%
of all SNP probeset intensities in the Transgenic2 sam-
ple show an increase in copy numbers (CNs), and 10%
are decreased compared to the normal samples; in Trans-
genic1 the number of SNPs with a decrease in CNA is
even higher (up to 15%). A further increase in CNA could
be observed in both tumor samples. Here, approximately
21% of all SNPs show a decrease and an additional 21%
show an increase in CN. The percentages in CN changes
indicate a progressive increase of CNA from normal to
transgenic and then tumor within our model. The high-
est percentage of CNA could be found in both cell line
samples with a total change of 46.5% (sensitive cell line)
and 45% (resistant cell line) of all SNP copy number val-
ues. Interestingly, comparable cell lines equally exhibit the
most diﬀerentially expressed genes [3]. This reveals that
considerableaberrationstakeplaceduringcellcultivation.
For comparison we analyzed recently published data
from Liu and colleagues [25], who have established
a PIK3CA-driven breast cancer model conditionallyStandfuß etal. BMCCancer 2012, 12:380 Page 4 of 15
http://www.biomedcentral.com/1471-2407/12/380
SNP array data 
Reference
Meanof
Normal1 and2
SNP CNA segCNA
highly
slightly
un-
changed
slightly
highly
decreased increased
CNA                                       CNA
categorization
DNAcopy (> 3 SNPs
per segment)
Expression data 
Impact of gene
CN on 
expression
log2ratio
Figure 2 Road map of the experimental approach. We calculated
the CNs from eight experiments (shown as purple box), built up a
reference (mean signal intensity of Normal1 and Normal2) and
determined the SNP CNAs for each sample against the reference. To
assess the chromosomal segments we used the circular binary
segmentation algorithm [26] with the restriction that adjacent SNPs
with similar log2-ratios are necessary to form a segment (SNP CNAs
are shown as green circles and the calculated segment segCNA is
given as a red line). The SNP CNAs and segCNA values are categorized
into ﬁve groups that are colored in the same manner as in Figure 3.
Further, the SNP data were compared with gene expression data
(given as a purple box) from the same samples.
expressing PIK3CA. CN analyses were carried out for
six recurrent tumor samples with the Aﬀymetrix Mouse
Diversity Genotyping Array. A total change in CNA of
about 26% can be identiﬁed in tumors RCT-D782 and
RCT-D419; 16% to 21% of all SNPs in the remaining
tumors show a copy number alteration. This is compa-
rable to the changes detected in our transgenic samples.
In fact, less changes in SNP copy numbers were found
in the recurrent tumor samples than in both WAP-SVT/t
tumor samples in our study. This may be explained by
thediﬀerencesintumordevelopmentwhichbecameobvi-
ous in the mean latency of the tumor survival data: seven
month for the PIK3CA-tumors in contrast to only three
months in the WAP-SVT/t mice (see Kaplan-Meier sur-
vival curve in Figure 1F and supplemental Figure S1,
Additional ﬁle 2).
Detection of continuous CNA regions
The individual CNA of a single SNP may not be relevant
or error-prone, hence we focused our research on genome
reorganization. We addressed the purpose of continu-
ous CNA detection on chromosomal regions and named
these regions “chromosomal segments” (segCNA). The
chromosomal segmentation of adjacent SNPs with similar
log2-ratio values was calculated using the circular binary
segmentation algorithm (CBS algorithm) introduced by
Olshen et al. [26]. In both normal samples a similar num-
ber of about 70 distinct segments was detected. The
number of calculated segments for the transgenic sam-
ples diﬀered from 760 (Transgenic1) to 292 (Transgenic2)
segments (see Table S2 in Additional ﬁle 3). A compara-
ble diﬀerence in the number of segments was found in
both cell line samples with 705 (sensitive cell line) and 354
(resistant cell line) segments calculated. In the tumors the
number of segments in both samples also diﬀer remark-
able, by a factor of 7. 1,241 delimited segments were
calculated in the Tumor1 sample whereas only 184 seg-
mentswerefoundintheTumor2sample.Thisindicatesan
individual development of DNA reorganization for each
sample during tumorigenesis. Although the SNP copy
number alterations between both tumor samples were
comparable, signiﬁcant changes in chromosomal segmen-
tation were found (see Tumor1 and Tumor2 in Table S2,
Additional ﬁle 3). This can be explained by the CBS algo-
rithm [26]. Only adjacent SNPs with a concordant signal
intensity occur in contiguous regions of the chromosome.
In contrast, the number of segments found in all six recur-
rent tumor samples diﬀer from 31 segments in RCT-D782
to85segmentsinRCT-E472.Correspondingtoourtumor
samples we found two groups with signiﬁcant diﬀerences
in number of segments: group 1 having 31 to 42 segments
in each sample, and group 2 having 68 to 85 segments
per sample. This underlines the diﬀerences in both mod-
els and the individual development found for the copy
number alteration analysis of individual SNPs. Two of the
recurrent tumors (RCT-D782 and RCT-E565) of group 1
were found to retain a high abundance of active p-AKT
and phospho-S6 ribosomal protein (p-S6RP); whereas two
tumors (RCT-E472 and RCT-C658) of group 2 show aStandfuß etal. BMCCancer 2012, 12:380 Page 5 of 15
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Figure 3 SNP and segmental copy number alteration. The percentage of SNP copy number values (A) and segmental copy number variations
(B) was assigned to four groups and is illustrated. Log2-ratio values smaller than -0.6 are colored in dark blue, values ranging from -0.6 to -0.2 in light
blue, log2-ratio values between 0.2 and 0.6 in orange and values greater than 0.6 in red. (A) Comparing the bars, one can see an increase in CNA
from normal (∼ 4%) to transgenic (∼ 20 - 25%) and to tumor (∼ 40%). The copy number alterations in both SV40T/t cell lines are even higher
compared to those in tumor (see Table S3A in Additional ﬁle 5 for entire CNA data). (B) In both normal samples about 76% of the calculated
segments show no signiﬁcant copy number alterations compared to the reference. An increase in CNA of 2% to 3% can be observed when
comparing the transgenic samples to the normal samples, and by about 20% when comparing the tumor samples to the normal samples. The
highest percentages of segCN were found in the Tumor1 and in the tumor sens. cell line. As observed in the number of segments the recurrent
tumor samples form two groups with diﬀerent magnitude of CNA (see Table S3B in Additional ﬁle 5 for entire segCNA data). A characteristic
increase in segmental CN can be shown when comparing the stages of our model (see Figure 1).Standfuß etal. BMCCancer 2012, 12:380 Page 6 of 15
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low abundance [25]. Although diﬀerences in segmenta-
tion were detected in both WAP-SVT/t tumor samples,
about 9% of the calculated breakpoints in Tumor2 were
also found in Tumor1 (see most inner circular track in
Figure S4, Additional ﬁle 4). This indicates that even
thoughthesegmentationpatternmaybediﬀerentforeach
sample, they may share a common set of chromosomal
breakpoints inducing similar reorganization patterns.
Percentage of segment CN
As shown in Figure 3B the percentage of changed seg-
ment copy number (segCN) values in the tumor sam-
ples is remarkably higher than in the normal and the
transgenic samples (by more than 50%). Interestingly, the
amount of segments with a decrease in segCN is higher
(value < -0.2) than those with an increase. This implies
that deletion events are more frequent than ampliﬁca-
tions (see Figure 3B and Table S3B in Additional ﬁle 5).
The apparent increase in segCN of about 26% in Tumor2
is due to the small total number of 176 segments, com-
pared to 1241 segments in Tumor1. The percentage of
segmental copy number alteration of all recurrent tumor
samples (published by Liu et al. [25]) is smaller than in
the WAP-SVT/t tumor samples mentioned previously.
Again, two groups can be identiﬁed. A variation in segCN
was found for 13% to 20% of all segments in one group
(RCT-D782, RCT-D565, RCT-D419), and in 33% to 35%
of all segments in another. Moreover, as indicated by the
diﬀerent numbers of ampliﬁcation and deletion events
(see Figure 3B), it is obvious that tumor samples are
heterogeneous.
Segmentation patterns
Log2-ratio SNP intensities were used to calculate the con-
tinuous regions of CNAs (called chromosomal segmen-
tation), using the circular binary segmentation algorithm
[26]. Characteristic patterns in segment copy number
alterations (segCNAs) emerging in transgenic samples
and further fragmented in tumor were found when ana-
lyzing the segmentation results. As illustrated in Figure S3
(see Additional ﬁle 6), a diﬀerent segmentation of chro-
mosome 6 within each sample was found. Additionally,
an increase in segCNA can be found for each stage of
the model. Not only diﬀerences in segment copy numbers
themselves, but also diﬀerent segmental positions (break-
point positions)were detected when comparing the stages
and samples. When taking a closer look at the Normal1,
Transgenic1, Tumor1 and cell line samples, characteris-
tic segmentation patterns can be observed. In Figure 4 a
section of chromosome 5 (55 Mb to 85 Mb) is shown for
each sample of all four model stages. No segmentation or
breakpoints were found in the Normal1 sample; in con-
trast 14 segments with a log2-ratio value between -2 and
0.24 were detected in both transgenic samples. It is not
only the case, that the number of segments is higher as
summarizedinTableS2,Additionalﬁle3,orthatnewseg-
ments can be detected from the normal to the transgenic
and the tumor samples, but also, the segments detected in
tumorsamplesaremostlyfragmentsfromsegmentsfound
in the transgenic sample (as illustrated in Figure 4). These
segmentationpatternsindicatepredisposedchromosomal
breakpoints. We think these breakpoints can be relevant
as a prognostic parameter for tumor progression.
ComparisonofCNstudies
In comparing diﬀerent CNA studies, one ﬁnd only a weak
overlap of segmental positions, segment length and copy
number values [17]. Agam et al. [17] found 1,477 loss
events and 499 gain events across seven mouse strains.
21 candidate regions of high-level DNA ampliﬁcation
were found in diﬀerent carcinoma samples by Zhao et al.
in 2004 [19]. Egan et al. [28] analyzed diﬀerent mouse
strains by tiling array CGH experiments and identiﬁed 38
CNAs for multiple probes and 23 segmental CNAs. Not
only diﬀerent segmentation algorithms and diﬀerences in
probe hybridization, but also diﬀerent types of microarray
designs (aCGH, oligonucleotide) and diﬀerent platforms
may cause the problems. In their study Agam et al. [17]
referred to the overlap of two sets of CNA between tech-
nical replicates. This overlap was compared to the overlap
of CNAs called in animals of the same strain. Using the
same algorithm and platform, they could show that more
consistent results were produced by technical replicates
rather than by biological ones.
Segmentation and gene expression
To survey a possible correlation of gene expression and
copy number variation, the method of direct comparison
w a su s e dt oe v a l u a t et h ec o r r e l a t i o no fc o p yn u m b e ra n d
gene expression. We compared the impact of the copy
number variation for diﬀerent genomic regions on the
resulting gene expressions for the top 500 diﬀerentially
expressedgenesforbothnormal,theTransgenic1,andthe
Tumor1 samples (see Methods). As shown in Table 1, 399
of 5,350 SNPs (see Table 1, underlined) in coding regions
show a direct correlation, that implies a concordance of
7.5%: 358 SNPs within 330 up-regulated genes show an
increase in copy number, and 41 SNPs show a decrease in
copy number for 170 down-regulated genes. Altogether,
few direct correlations between SNP copy number and
gene expression were found. Analyzing the correlation
between segmental copy numbers and gene expression
(see Table 2), even a smaller concordance of 2.5% was
found for ampliﬁed segments within up-regulated genes,
and no concordance was found for deletions. Analyzing
the association of CNA and gene expression in 44 pri-
mary tumors of 10 breast cancer patients, Pollack and
co-workers [18] found that 62% of the highly ampliﬁedStandfuß etal. BMCCancer 2012, 12:380 Page 7 of 15
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Figure 4 Segmentation diﬀerences in developmental stages. Fragmentation patterns which have frequently been observed are shown here; a
section of chromosome 5 (55Mb to 85Mb) is taken as an example. Comparing Transgenic1 and Tumor1, one can ﬁnd not only an increase in copy
number alteration, but also a progressive fragmentation of previously found segments. These fragmentation patterns can be found in all WAP-SVT/t
derived samples. The results for Normal2, Transgenic2 and Tumor2 were comparable (data not shown).Standfuß etal. BMCCancer 2012, 12:380 Page 8 of 15
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Table 1 Correlation of Gene expression and SNP copy number
Gene expression Number of genes Number of SNPs with
Ampliﬁcation Deletion No variation Total
up 330 358 104 3032 3494
down 170 121 41 1694 1856
479 145 4726 5350
The correlation between the top 500 diﬀerentially expressed genes and the copy number of SNPs found within the coding regions was examined. For each up-o r
down-regulated gene the number of SNPs with an increase (ampliﬁcation), a decrease (deletion) or no variation in copy number were counted. All in all, 5,350 SNPs
were found within diﬀerentially expressed 500 genes; 7.5% of them had signiﬁcant variations in SNP copy numbers (underlined). For merely 358 SNPs within the 330
up-regulated genes, an increased copy number was detected. For the 170 down-regulated genes only 41 SNPs were found to have a decrease in copy number.
genes show moderate or high gene expression. Compar-
ing the impact of CNAs to gene expression Lee et al.
[29] summarize that it is no simple relation. They state
that positive correlations can often be found (but not
always), and other ﬁndings could be explained by other
mechanisms, such as e.g. distant interactions and indirect
regulation.
However, a few examples of direct correlation to
gene expression can be identiﬁed in some chromoso-
mal regions. As an example, a region of chromosome
6 in Normal1 (a), Transgenic1 (b) and Tumor1 (c) is
depicted in Figure 5, showing the chromosomal region
from 17.4 Mb to 18.6 Mb. Four segments with a high
copy number alteration in tumor (c) and 6 protein cod-
ing genes (d) aﬀected by CNA were found within this
region. Comparing the gene positions to the calculated
breakpoints, the ﬁrst chromosomal breakpoint could be
identiﬁed within the Met gene, the second between the
Asz1andtheCftr geneandthethirdaround18.46Mb.Not
only was an increase in copy number variations for three
segments detected, but also a signiﬁcant up-regulation for
Met (about 3.8), Capza2 (1.8 to 2.7) and St7 (about 1.9)
was detected. Met is a well known proto-oncogene which
shows a high expression in diﬀerent tumor entities [30],
e.g. in breast cancer [31,32]. Even though, an increased
segCN was computed for Capza2, St7, Wnt2 and Asz1,a
signiﬁcant up-regulation in gene expression was found for
Met, Capza2 and St7. Neither the CNA within this region
nor the diﬀerential gene expression of the listed genes can
be found any of the other samples. Modeling transcrip-
tional eﬀects of CN in glioblastoma, J¨ ornsten et al. [20]
state that some CNA-mRNA associations may be erro-
neous since CNAs often span multiple genes. Using CNA-
driven networks they found 512 associations between
gene expression and CNA in the glioblastoma data of 186
patients. Applying copy number eQTL analysis (eQTL -
mapping of quantitative trait loci regulating gene expres-
sion) to 20,145 mouse genes in their study, Ahn et al.
[23] showed signiﬁcant overlaps with existing networks
and found that signiﬁcant genes were highly connected
as compared to non-essential genes. At the moment we
are not able to apply network-based methods to our data
due to the small number of experiments. We will however
in future research address molecular networks of tumor
progression in our model.
qPCRveriﬁcation
We reviewed the previously described CN ampliﬁ-
cation by qPCR analyses for the unampliﬁed region
(chr6:17.3MB-17.5MB, log2-ratio = 0.3 in Tumor1)
including parts of the Met gene and the ampliﬁed region
(chr6:17.5MB-18.14MB, log2-ratio = 1.75). One primer
pair was located within the unampliﬁed segment, two
pairs within the ampliﬁed segment. In Figure S2 (see
Additional ﬁle 7) the results of qPCR analyses of Normal1,
Normal2, Tumor1 and Tumor2 are shown. Only in
Tumor1 an ampliﬁcation was found, for both primer pairs
up to six-fold within the region expected to be ampliﬁed.
Table 2 Correlation of Gene expression and segment copy number
Gene expression Number of genes Number of segments with
Ampliﬁcation Deletion No variation Total
up 330 8 0 305 313
down 170 2 0 213 215
10 0 518 528
The correlation between the top 500 diﬀerentially expressed genes and the segment copy numbers found within the coding regions was examined. For each up- or
down-regulated gene the number of segments with an increase (ampliﬁcation), a decrease (deletion) or no variation in copy number values were counted.
Interestingly, a decrease in segmental copy number was neither found for up-regulated nor for down-regulated genes. Only 8 of 313 segments associated to 330
up-regulated genes show an increase in segmental copy number, whereas the remaining 98.48% of the segments show no signiﬁcant change.Standfuß etal. BMCCancer 2012, 12:380 Page 9 of 15
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Figure 5 Impact of copy number alteration on gene expression for a region of chromosome 6. The impact of the copy number variation on
the gene expression for a section of chromosome 6 (17.4 Mb to 18.6 Mb) is shown here. Six genes showing a signiﬁcant up-regulation in gene
expression are located within this region, including Met, Capza2, St7. The segmentation in the normal, the transgenic and the tumor samples are
s h o w ni ns u b p l o t sa, b and c, respectively. The gene positions are illustrated in (d) and in each plot, illustrating the copy number variation. One
breakpoint was found within the Met gene resulting in a segment with more than a 3.5-fold ampliﬁcation in CN.Standfuß etal. BMCCancer 2012, 12:380 Page 10 of 15
http://www.biomedcentral.com/1471-2407/12/380
Figure 6 Motifs. The six motifs detected in 285 inter-segment regions of Tumor1 are presented. The lengths of the motifs vary from 29 to 40 bp
with 49 and 50 common sites.
Compared to the normal samples and the Tumor2 sam-
ple, a slight ampliﬁcation was detected within the region
expected to be unampliﬁed. This is reﬂected in the small
log2-ratio change of 0.3 (1.23-fold) detected. Both results
are in accordance with the calculated segment intensity
values from our CNA data (see Figure 5).Standfuß etal. BMCCancer 2012, 12:380 Page 11 of 15
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Motif search and repeats
Segmental positions depend on the chromosomal loca-
tion of the SNPs, but the distance between two adjacent
segments may span about 4kb on average. These inter-
segment regions (ISRs) comprise hypothetical break-
points but the exact positions were not detectable.
Hence, motif discovery was performed (with MEME Suite
[33]) for motif identiﬁcation in hypothetical breakpoint
sequences. We present here six motifs detected within
the 285 inter-segment regions of Tumor1 (see Figure S4
in Additional ﬁle 4 for motif positions). As shown in
Figure 6, motif 1 consists of multiple CTC[T/C] repeats
and can be found in at least 50 sites. As with motif 1,
motif 6 consists of multiple [CA]n repeats with a total
length of 39 bp. The motifs show further repeats besides
the previously mentioned ones, eg. [C]3 and [C]5 in motif
2o rG G [ C / A ] 2 in motif 4. These simple repeats have
been conﬁrmed by a previous study by Puttagunta et al.
[34]. This study revealed that simple repeat sequences
may be involved in chromosome breaks. Most of these
simple repeats consist of a multiple sequence of dinu-
cleotide repeats, like [CT]n [34] and [TA]n [35] repeats.
Repeats of [TCTG]n and [GTCTCT]n [34] have also been
observed within chromosomal breakpoints. Ruiz-Herrera
et al. also showed the correspondence between fragile
sitelocationandthepositionsofevolutionarybreakpoints
[36]. As stated by Ruiz-Herrera, microsatellites are known
to be an additional underlying mechanism behind chro-
mosomal instability, characterizing some fragile sites in
human DNA, and in constitutional human chromosomal
disorders. Not only are microsatellites repeats of varying
length, but they have also been found to be particularly
AT-rich [37]. Furthermore, palindromic AT-rich repeats
are found to be related to human chromosomal aberra-
tions [38,39]. We determined the associated GO terms
(Gene Ontology) of the six motifs using GOMO [40]
(Gene Ontology for Motifs, from MEME suite [33]); the
top GO term predictions are listed in Table 3. The asso-
ciation of the term “positive regulation of transcription
from RNA polymerase II promoter” is very common to
motifs 1 and 5. Motif 1 was also identiﬁed to be associated
to a “negative regulation of transcription from RNA poly-
merase II promoter”. Interestingly, only a cellular compo-
nent association was found for motif 3 and no association
was found for motif 4. Additionally, three of six motifs
were found to be associated to “transcription factor activ-
ity”.Comparingthe motifsfound withintheinter-segment
regions (ISRs), seventeen matches were computed search-
ing the Uniprobe mouse database with TomTom [41].
Most motif matches were found for motif 2, including
Zinc ﬁnger protein motifs, growth factor response motifs
and homeodomains. In summary, an association to DNA,
RNA and protein interaction as well as an inﬂuence on
transcriptional regulation can be found for four of the six
Table 3 Motif annotations
Motif GO term predictions Motif match
1 BP - positive regulation of transcription nomatch
from RNA polymerase II promoter
BP - transcription
BP - negative regulation of transcription
from RNA polymerase II promoter complex
MF - transcription activator activity
2 MF - transcription factor activity Zfp740, Zfp281,
MF - sequence-speciﬁc DNA binding Sox13, Sp4,
BP - transcription Pitx3, Smad3,
BP - inner ear morphogenesis Egr1, Ascl2,
BP - proximal/distal pattern formation Zfp410
3 noprediction Spdef, Tcfe2a
4 noprediction Zbtb3
5 MF - sequence-speciﬁc DNA binding nomatch
MF - transcription factor activity
BP - positive regulation of transcription from
RNA polymerase II promoter
MF - calcium ion binding
6 MF - receptor binding Gm397
BP - axon guidance
BP - positive regulation of immune response
BP - defense response
Motifs found by motif search in 285 segments of the Tumor1 sample are
depicted in Figure 6. GO term associations using GOMO [40] and the motif
matches against the UniProbe [42] database using TomTom [41] were computed
for each motif. In cases of motif 1, motif 2, motif 5 and motif 6 Gene Ontology
term associations were found. Biological processes are abbreviated by BP,
molecular functions by MF. Nine motifs of the UniProbe database match motif 2
and only two UniProbe motifs match motif 3.
previously presented motifs. These motif characteristics
are indicated not only by motif associations to GO terms
but also by motif matches to validated and well known
motifs. Motifs having neither a GO term prediction nor
matching known motifs, may still by further analyses be
shown to contribute to breakpoint prediction.
Conclusions
In this work we study the CNAs of a four stage tumori-
genesis model. Our model includes copy number analyses
in a normal, in a transgenic, and in a tumor phenotype as
well as in tumor-derived cell lines. We analyzed the copy
number (CN) of mouse mammary gland epithelial cells
and compared their gene expression to the copy number
alterations detected. Here, we demonstrated a stepwise
increase in fragmentation of mouse chromosomes during
tumorigenesis with non-random fragmentation patterns
within each stage of our model. Nearly 10% of all break-
p o i n t sd e t e c t e di nt h eT u m o r 2s a m p l ew e r ef o u n dt ob eStandfuß etal. BMCCancer 2012, 12:380 Page 12 of 15
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common with the Tumor1 sample. This indicates that
individual breakpoints as well as common breakpoint pat-
terns contribute to tumor progression. Further analyses
will have to conﬁrm the impact of these common break-
points on tumorigenesis. The distinctive fragmentation
showing a stepwise increase of copy numbers suggest pre-
disposed or conserved breakpoints which promote onco-
genesis. The limitation of this work was the small number
of samples for the comparison of copy numbers and gene
expression, making it hard to determine the exact corre-
lation between them, also making the determination of
conserved or common breakpoints within one stage dif-
ﬁcult. Therefore, further experiments on a larger number
of samples will be undertaken to ﬁnd a subset of break-
points or chromosomal regions common within a stage.
Animal models provide a reliable basis for further exper-
iments. Samples from transgenic SVT/t mice during the
ﬁrst lactation period are comparable to early tumor stages
in human breast cancer [43]. A goal of this work was to
discriminate between early and late genomic changes in
tumor development. The profound identiﬁcation of early
stages in breast cancer would be helpful for diagnosis
and could inﬂuence the therapeutic decisions. Further,
we might detect a chronology in genomic reorganiza-
tion during tumorigenesis. Nevertheless, a large number
of experiments is necessary if one is to study the impact
of CNAs and breakpoints on gene expression diﬀerences
during tumor development. The six motifs identiﬁed in
inter-segment regions (ISRs) show a signiﬁcant appear-
ance in more than 40 diﬀerent ISRs. Two of these six
motifs were found to have no GO term associations, but
they match known motifs from the UniProbe database.
Two other motifs found within the ISRs match no known
motifs of the UniProbe, but an association to biological
processes and molecular functions could be predicted.
Further analyses have to be made, analyzing the exact
functionofthesemotifsinISRsandtheireﬀectonCNand
chromosomal breakpoints.
Methods
Material
Mammary gland tissue samples from six NMRI mice
were analyzed. Two samples originated from normal non-
transgenic mice, and four from WAP-SVT/t transgenic
mice (see Figure 1). The two transgenic samples were
derived from WAP-SVT/t mice on the ﬁrst day of lac-
tation. Moreover, two breast cancer samples originated
from WAP-SVT/t mice that had developed cancer after
the ﬁrst lactation period. Additionally, two samples were
derived from the 762TuD cell lines as described in the
work of Klein et al. [24]. The cytosine arabinoside sen-
sitive sample SVTneg1 (CAs) was in passage 111 and
the cytosine arabinoside resistant sample SVTneg1 (CAr)
was in passage 23 when DNA was taken for analyses.
T h ed a t ah a v eb e e nd e p o s i t e di nG E Od a t a b a s e[ 4 4 ]
and are accessible through GEO Series accession num-
ber GSE35873 (http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE35873). The induction of tumor forma-
tion by SV40-T-antigen synthesis was tested in a previous
work by Santarelli et al. [45].
For further comparison, six recurrent tumor samples of
PIK3CA-driven mammary tumors provided by Liu et al.
[25] were used for the analyses (data available at NCBI
GEO database [44], accession number GSE27691).
Mouse SNP analyses
DNA was extracted using Purelink Genomic DNA Kit
(K1820, Invitrogen) in accordance with the manufac-
turer’s protocol. The genotyping analyses were car-
ried out at Atlas Biolabs GmbH (Berlin, Germany)
using Aﬀymetrix Mouse Diversity Array (MOUSE-
DIVm520650) [see supplement for protocol, Additional
ﬁle 8]. The array design was described by Yang et al. in
2009 [27]. Normalization and allele summarization were
performed with the BRLMM-P algorithm provided by
the Aﬀymetrix Power Tools Software Package (version
1.14.3.1). To compare the total signal intensity distribu-
tionsofallsamples,intensitiesofbothallelesforeachSNP
were added up. Copy number alteration (CNA) for each
SNP was computed as log2-ratios of each sample and a
reference dataset. The reference for each SNP was calcu-
lated as the mean signal intensity of both normal samples
(Normal1 and Normal2). In the case of the six recurrent
tumor samples the ratio was computed using the normal
sample provided by Liu et. al. [25].
Segmentation analyses and motif ﬁnding
All statistical analyses were performed using R (version
2.14). Diﬀerences in copy number (CN) and segmen-
tation of each chromosome were calculated with the
DNAcopy package (version 1.28.0) of Bioconductor (ver-
sion 2.9) [46], using log2-ratio values. The DNAcopy
package implements the circular binary segmentation
algorithm introduced by Olshen et al. [26]. Continu-
ous CNA regions (segments) were predicted ﬁnding a
’change-point’ between two groups of SNP intensity val-
ues according to their common distribution function.
The parameters of the signiﬁcance level α and the stan-
dard deviation SD were tested to assess the number of
resulting segments (data not shown). Here the parameter
settings of α = 0.001, SD = 0.5 and “sd.undo” were used.
Motif search was performed in inter-segment regions
(ISR) of the Tumor1 sample using the MEME Suite [33].
To enhance the signiﬁcance, only inter-segment regions
of two adjacent segments with a diﬀerence in segment
meanofatleast0.8wereanalyzed.TheMEMEparameters
were set to a minimum motif width of 15 bp and a max-
imum width of 40 bp. Motifs found within the ISR wereStandfuß etal. BMCCancer 2012, 12:380 Page 13 of 15
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annotated using GOMO [40] and compared to known
motifs of the UniProbe database [42] using TomTom [41].
Gene expression analyses
RNA was extracted from frozen tissue segments with
RNAzol (PeQLab, Biotechnology GmbH) in accordance
with the manufacturer’s protocol. RNA was hybridized
to Aﬀymetrix’s Mouse Expression Set 430 A; chips were
scanned with the GeneChip Scanner 3000 and VSN
normalization was applied to the gene expression data
for normalization. Gene expression data (published by
Klein et al. [43]) can be found on NCBI Gene Expres-
sion Omnibus database [44] (GEO series accession num-
ber GSE6772; see Additional ﬁle 1 for sample accession
numbers).Diﬀerentiallyexpressedgenesweredetermined
based on the false discovery rate adjusted p-value (FDR
p-value), using the limma package [47] (version 3.10.1)
of Bioconductor. For comparison of the gene expression
and the copy number variation, the 500 top-ranked dif-
ferentially expressed genes between the two normal and
the two tumor samples were computed. It was analyzed
w h e t h e ra ni n c r e a s eo rd e c r e a s eo fag e n eC Ni n ﬂ u e n c e s
the gene expression.
Quantitative real-time polymerase chain reaction
DNA samples from two non-transgenic NMRI mice on
the ﬁrst day of lactation and two WAP-SVT/t tumor
samples were used for quantitative PCR analysis. Quan-
titative real-time polymerase chain reaction (qPCR) was
performed on optical grade PCR plate (BioRad Labo-
ratories, Munich, Germany) using a BioRad iQ iCycler
Detection System (BioRad Laboratories). All qPCRs were
performed in triplicate in a total volume of 20 μl, con-
taining 15 ng of gDNA sample, 20 nmol of each primer,
and 10 μl of SensiFAST SYBR Lo-ROX Kit (Bioline,
Luckenwalde, Germany). Baseline setting, Ct values and
eﬃciency of PCR reactionswere determinedwith the help
of LinRegPCR version 12.16 [48,49]. Relative quantities
of the gene to be studied were normalized to glyceralde-
hyde 3-phosphate dehydrogenase quantities. Each experi-
ment was carried out in triplicate. The following primers
were used for qPCR analysis: for the unampliﬁed region
Met ua s 5’-TGCTTGGTGACTTTGGTGTGGT-3’ and
Met ua1 as 5’-AGCAGGCAGAAATGCGTGAAAGT-3’;
for the ampliﬁed region Met am 1 s 5’-ACGTGGAGTT
CAGCAGCAATCTGT-3’ and Met am1 as 5’-TGGCTT
GGGATTAGGGCTGTTCT-3’ as well as Met am2 s5 ’ -
CCTCCAGCACGGGATTCAACCA-3’ and Met am2 as
5’-TGACTACATGCCGCGCCTAAC-3’.
Survival analysis
We analyzed the time it took for tumors to develop in
64 female mice. Time was measured from ﬁrst day of
mating until the ﬁnding of a tumor; after a tumor was
found the mice were euthanized. The Kaplan-Meier sur-
vival curve was computed using the R package Survival
(version 2.36-10).
Array annotations and genomic information
SNP array annotations of release 31 were downloaded
from Aﬀymetrix’s website and used for SNP copy num-
ber analyses and segmentation analyses. Mouse DNA
sequences were downloaded from Ensembl [50] (release
65, Mouse Genome Assembly NCBI m37).
Animal care
All animal experiments were carried out in accordance
with the protocols of the animal care committee of the
Senate of Berlin.
Additional ﬁles
Additional ﬁle 1: Sample description. Table S1: The sample names used
in this publication are listed. GEO accession numbers for each experiment
can be found in this table. For the Transgenic2 (183T8) sample no gene
expression data was available.
Additional ﬁle 2: Kaplan-Meier curve. Figure S1: This ﬁgure illustrates
the Kaplan-Meier curve. The x-axis depicts the duration from the ﬁrst
mating and the ﬁnding of tumor formation. All mice were euthanized as
soon as a tumor was found. All 64 mice developed breast cancer within
less than 200 days after their ﬁrst day of pregnancy. In fact, about 60% of
the animals showed a tumor formation within the ﬁrst 100 days.
Additional ﬁle 3: Number of segments computed for each sample.
Table S2: This table lists the number of segments calculated for each
chromosome in each of the 14 samples.
Additional ﬁle 4: Copy number alteration and motif position in
Tumor1 sample. Figure S4: Copy number alterations are depicted in the
outer cirular plot. The ﬁve inner circular plots illustrate the motif positions
of motif 1 (blue), motif 2 (orange), motif 3 (green), motif 4 (red), motif 5
(purple) and motif 6 (grey). Thicker lines illustrate a short distance of two
motif positions. Common breakpoints of Tumor2 and Tumor1 samples are
illustrated in the most inner circular plot.
Additional ﬁle 5: Log2-ratio distribution. Table S3: (A) and (B): Tables
listing the alteration of single SNP log2-ratio (as shown in Figure 3A) and
the alteration of segment log2-ratio values (as shown in Figure 3B).
Additional ﬁle 6: Segmentation in diﬀerent samples. Figure S3:
Diﬀerent segmentation results for chromosome 6 in all samples is
depicted. Comparing Normal1 to Transgenic1 and to Tumor1, one can see
an increase in both the fragmentation and the copy number. Comparable
alterations can also be found in both SV40 cell line samples. By
comparison, the Transgenic2 and Tumor2 samples show less
fragmentations. Interestingly, even more segments can be identiﬁed in the
Transgenic2 sample than in Tumor2.
Additional ﬁle 7: Plot of qPCR results. Figure S2: Barplot illustrating the
qPCR results for the three previously mentioned regions of chromosome 6.
Additionalﬁle8: GenotypingProtocol.Protocolofgenotypinganalyses.
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